Results 151 to 160 of about 2,048,259 (212)

Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. [PDF]

open access: yesBlood Adv, 2019
Berger G   +15 more
europepmc   +1 more source

Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts. [PDF]

open access: yesBlood Cancer J, 2017
Martín I   +13 more
europepmc   +1 more source

Congenital Sideroblastic Anemia with Persistent Neutropenia in a Female Infant: A Case Report of Pyridoxine Responsiveness

open access: yesIndian Journal of Medical and Paediatric Oncology
Hussnain Ashfaq   +3 more
doaj   +1 more source

Refractory Anemia With Ring Sideroblasts

open access: yesBest Practice and Research in Clinical Haematology, 2013
Refractory anemia with ring sideroblasts (RARS) is a subtype of myelodysplastic syndrome (MDS) characterized by 15% or more ring sideroblasts in the bone marrow according to the WHO classification. After Perls staining, ring sideroblasts are defined as erythroblasts in which there are 5 or more siderotic granules covering at least a third of the ...
Mario Cazzola, Luca Malcovati
exaly   +6 more sources

Myelodysplastic syndromes with ring sideroblasts

Hematological Oncology, 2023
Abstract Myelodysplastic syndromes (MDS) are acquired bone marrow malignant disorders characterized by ineffective hematopoiesis, resulting from a complex interaction between genetic and epigenetic mutations, alterations of the marrow microenvironment, and the immune system. In 2001, the World Health Organization (
Antonella Bruzzese   +12 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy